Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
Background
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Items 201–300 of 476
Mansoor, N., Abel, B., Scriba, T. J., Hughes, J., de Kock, M., Tameris, M. D., Mlenjeni, S., Denation, L., Little, F., Gelderbloem, S., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.09.006 · Cited by 33
“In HIV-infected adults, loss of naïve T cells is the result of increased immune differentiation, driven by immune activation, which is characteristic of HIV-1 infection [32; 33;34;35].”
BackgroundWalker, L. J., Marrinan, E., Muenchhoff, M., Ferguson, J. G., Kløverpris, H. N., Cheroutre, H., Barnes, E. J., Goulder, P., & Klenerman, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00223 · Cited by 34
“HIV-1 infection is associated with the development of prematurely senescent immune system; massive activation of the whole CD8 T cell population is observed during acute infection (28) and a large population of CD28−CD27−CD57+ T cells is found within bulk CD8 T cells.”
BackgroundResultMaternal—Fetal rejection reactions are unconstrained in preeclamptic women
Nguyen, T., Kahn, D. A., & Loewendorf, A. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188250 · Cited by 32
“The progression of CD8+ T cell differentiation from CD27+CD28+ to CD27+CD28- and lastly CD27-CD28- has been observed repeatedly in human viral infections (Influenza, HCV, EBV, HIV, and CMV), confirmed with telomere length studies and in in vitro assays using human cells [18, 19].”
BackgroundBushara, O., Krogh, K., Weinberg, S. E., Finkelman, B. S., Sun, L., Liao, J., & Yang, G. (2021) · Pathobiology · doi:10.1159/000518758 · Cited by 32
Pickler, L., Hayashi, R. M., Lourenco, M. C., Miglino, L. B., Caron, L. F., Beirão, B. C. B., Silva, A. V. F., & Santín, E. (2012) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2012000100006 · Cited by 30
D’Abramo, A., Zingaropoli, M. A., Oliva, A., D’Agostino, C., Moghazi, S. A., Luca, G. D., Iannetta, M., Mastroianni, C. M., & Vullo, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/192594 · Cited by 33
Sforza, F., Nicoli, F., Gallerani, E., Finessi, V., Reali, E., Cafaro, A., Caputo, A., Ensoli, B., & Gavioli, R. (2014) · AIDS · doi:10.1097/qad.0000000000000315 · Cited by 29
Distinct aging profiles of CD8+ T cells in blood versus gastrointestinal mucosal compartments
Dock, J., Ramirez, C. M., Hultin, L. E., Hausner, M. A., Hultin, P. M., Elliott, J. E., Yang, O. O., Anton, P. A., Jamieson, B. D., & Effros, R. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182498 · Cited by 31
“These results are consistent with previous studies indicating that CD8 T cells become more activated with age [5, 65, 74].”
BackgroundResultHDL and persistent inflammation immunosuppression and catabolism syndrome
Barker, G., Winer, J., Guirgis, F. W., & Reddy, S. T. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000782 · Cited by 30
“These are terminally differentiated T cells that have lost CD28 (costimulatory molecule for T cell receptor activation) and also have an increased susceptibility to apoptotic signals [49].”
BackgroundHIV-mediated immune aging in young adults infected perinatally or during childhood
Fastenackels, S., Sauce, D., Vigouroux, C., Avettand-Fènoël, V., Bastard, J., Fellahi, S., Nailler, L., Arezes, E., Rouzioux, C., Warszawski, J., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002275 · Cited by 30
“CD57þ) often considered as cells approaching cellular senescence [9,10].”
BackgroundSelf-citationSimonetta, F., Hua, S., Lécuroux, C., Gérard, S., Boufassa, F., Sáez‐Cirión, A., Pancino, G., Goujard, C., Lambotte, O., Venet, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02013-14 · Cited by 30
“CD57 expression identifies senescent human T cells displaying a terminally differentiated phenotype (1, 10–12) and increases during HIV infection, probably as a result of chronic immune activation (11, 13).”
BackgroundCantisán, S., Torre-Cisneros, J., Lara, R., Rodríguez-Benot, A., Santos, F., Gutiérrez-Aroca, J., Gayoso, I., González-Padilla, M., Casal, M., Rivero, A., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00214-09 · Cited by 27
“An illustrative case would be HIV infection, in which the accumulation of virusspecific clones with features of replicative senescence has been correlated with disease progression (28).”
BackgroundBarbour, J. D., Ndhlovu, L. C., Tan, Q. X., Ho, T. N., Epling, L., Bredt, B. M., Levy, J. A., Hecht, F. M., & Sinclair, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004408 · Cited by 27
Statistical determination of threshold for cellular division in the CFSE-labeling assay
Liu, D., Yu, J., Chen, H., Reichman, R. C., Wu, H., & Jin, X. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.03.010 · Cited by 27
Lécuroux, C., Girault, I., Urrutia, A., Doisne, J., Deveau, C., Goujard, C., Meyer, L., Sinet, M., & Venet, A. (2008) · Blood · doi:10.1182/blood-2008-07-167601 · Cited by 32
Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients
Petrova, M., Maria, M., Nikolova, M., Magaev, S., Taskov, H., Nikolovska, D., & Krastev, Z. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i35.5711 · Cited by 29
CD28−CD8+ T cells do not contain unique clonotypes and are therefore dispensable
Weinberger, B., Welzl, K., Herndler‐Brandstetter, D., Parson, W., & Grubeck‐Loebenstein, B. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.08.008 · Cited by 26
Nyamweya, S., Townend, J., Zaman, A., Steele, S. J., Jeffries, D. J., Rowland-Jones, S. L., Whittle, H. C., Flanagan, K. L., & Jaye, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044411 · Cited by 26
“Chronic immune activation, a hallmark of HIV-1 infection [1], has been associated with disease progression [2,3] and has even been put forward as a stronger predictive factor for progression than CD4 T cell count or viral load [4,5].”
BackgroundSelf-citationSvane, I. M., Pedersen, A. E., Nikolajsen, K., & Zocca, M.-B. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.085 · Cited by 27
CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease
Palmer, B. E., Mack, D. G., Martin, A. D., Maier, L. A., & Fontenot, A. P. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.009 · Cited by 26
Saha, B., Choudhary, M. C., & Sarin, S. K. (2013) · AIDS · doi:10.1097/qad.0b013e32836285e4 · Cited by 26
George, A. F., Luo, X., Neidleman, J. A., Hoh, R., Vohra, P., Thomas, R., Shin, M., Lee, M. J., Blish, C. A., Deeks, S. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.803417 · Cited by 28
Katz, P. S., Siggins, R. W., Porretta, C., Armstrong, M. L., Zea, A. H., Mercante, D. E., Parsons, C. H., Veazey, R. S., Bagby, G. J., Nelson, S., et al. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.09.003 · Cited by 28
“Discussion PLWHA exhibit increased risk for age-related comorbidities including immune dysfunction and, ultimately, immunosenescence (Hirschhorn, Kaaya, Garrity, Chopyak, & Fawzi, 2012; Papagno et al., 2004).”
BackgroundLécuroux, C., Girault, I., Boutboul, F., Urrutia, A., Goujard, C., Meyer, L., Lambotte, O., Chaix, M., Martinez, V., Autran, B., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832e6634 · Cited by 28
“Strong generalized immune activation is commonly described during acute HIV infection [22,41].”
BackgroundLécuroux, C., Girault, I., Chéret, A., Versmisse, P., Nembot, G., Meyer, L., Rouzioux, C., Pancino, G., Venet, A., & Sáez‐Cirión, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059767 · Cited by 25
Jacobson, M. A., Dittmer, D. P., Sinclair, E., Martin, J. N., Deeks, S. G., Hunt, P. W., Mocarski, E. S., & Shiboski, C. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005277 · Cited by 25
“Replication of CMV, EBV and KSHV persists in many antiretroviral-suppressed, HIV-infected patients to a greater degree than in HIV-uninfected adults [9].”
BackgroundDíaz, L., Méndez‐Lagares, G., Correa‐Rocha, R., Pacheco, Y. M., Ferrando‐Martínez, S., Ruíz-Mateos, E., Pozo‐Balado, M. D. M., León-Luis, J. A. D., Gurbindo, M. D., de José, M. I., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318259254f · Cited by 28
“However, HIV-infected adults have reduced levels of naive CD8 T cells(15) that are not able to replace old senescent CD8 T cells.(6) One of the major changes that occur in HIV-viremic individuals is the accumulation of CD28-CD57+ T cells, particularly within the CD8 population.”
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells.
Nomura, L. E., Emu, B., Hoh, R., Haaland, P., Deeks, S. G., Martin, J. N., McCune, J. M., Nixon, D. F., & Maecker, H. T. (2006) · AIDS Research and Therapy · doi:10.1186/1742-6405-3-18 · Cited by 25
“Our observation of reduced CD8+ T cell IL-2 production is consistent with published reports about the lack of proliferative capacity of these cells in progressive HIV disease [6,15,22].”
BackgroundResultBeirão, B. C. B., Fávaro, C., Nakao, L. S., Caron, L. F., Zanata, S. M., & Mercadante, A. F. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.10.004 · Cited by 24
HIV/AIDS: Hormonal Contraception and HIV Disease Progression
Stringer, E., & Antonsen, E. (2008) · Clinical Infectious Diseases · doi:10.1086/591697 · Cited by 27
“Senescence of CD8+ T cells has also been suggested, although this has not been sufficiently investigated [26, 27].”
HIV-1 Infection Abrogates CD8+T Cell Mitogen-Activated Protein Kinase Signaling Responses
Crawford, T. Q., Ndhlovu, L. C., Tan, A., Carvidi, A. B., Hecht, F. M., Sinclair, E., & Barbour, J. D. (2011) · Journal of Virology · doi:10.1128/jvi.05682-11 · Cited by 24
“These are the same two memory differentiation stages that are themselves expanded in frequency in HIV-1 infection (2, 3, 22).”
BackgroundRönsholt, F. F., Ullum, H., Katzenstein, T. L., Gerstoft, J., & Ostrowski, S. R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825e7ac1 · Cited by 26
the CAPRISA 002 Study Team, Riou, C., Treurnicht, F. K., Abrahams, M.-R., Mlisana, K. P., Liu, M. K. P., Goonetilleke, N. P., Koup, R. A., Roederer, M., Karim, S. S. A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201488 · Cited by 27
Grady, B. P. X., Nanlohy, N. M., & van Baarle, D. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0065-0 · Cited by 27
“The CD27+CD57- immature CD4+ T cells from young IDU with HCV or HIV/HCV infection also had a lower RTL than healthy donors (p=0.056 and p 0.001 respectively).”
BackgroundInfluentialMechanisms regulating expansion of CD 8+ T cells during HIV ‐1 infection
Nasi, A., & Chiodi, F. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12722 · Cited by 25
Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection
Li, W., Syed, F., Yu, R., Yang, J., Xia, Y., Relich, R. F., Russell, P. M., Zhang, S., Khalili, M., Huang, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833310 · Cited by 26
“sGITRL 123 (140-905) 120 (85-178) 245 (163-345) P1, ***P2, ***P3”
InfluentialVenkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
Stem Cell Transplantation for Lymphoma Patients with HIV Infection
Michieli, M., Mazzucato, M., Tirelli, U., & Paoli, P. D. (2010) · Cell Transplantation · doi:10.3727/096368910x528076 · Cited by 22
Poudel‐Tandukar, K., Jacelon, C. S., Bertone‐Johnson, E. R., Palmer, P. H., & Poudel, K. C. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.08.005 · Cited by 23
Assessing ageing of individual T lymphocytes: Mission impossible?
Iancu, E. M., Speiser, D. E., & Rufer, N. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.005 · Cited by 23
Self-citationSlyker, J. A., John-Stewart, G. C., Dong, T., Lohman-Payne, B. L., Reilly, M., Atzberger, A., Taylor, S., Maleche‐Obimbo, E., Mbori‐Ngacha, D., & Rowland‐Jones, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020375 · Cited by 21
“The differentiation phenotype of infant HIV-specific CD8 T cells was similar to adults; HIV-specific CD8 T cells were primarily CD27CD28; a subset of infant CD8 T cells expressed both CD45RA and CD57 and were activated, suggesting terminal differentiation to an effector phenotype (limited in proliferative potential bu…”
BackgroundSelf-citationHarris, M., Burns, C. M., Becker, E. A., Braasch, A. T., Emma Gostick, D., Johnson, R. C., Broman, K. W., Price, D. A., Friedrich, T. C., & O’Connor, S. L. (2013) · Journal of Virology · doi:10.1128/jvi.00909-13 · Cited by 24
Hodowanec, A. C., Brady, K. E., Gao, W., Kincaid, S. L., Plants, J., Bahk, M., LANDAY, A. L., & Huhn, G. D. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829c6de0 · Cited by 21
CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection
Westrop, S. J., Moyle, G. J., Jackson, A., Nelson, M. R., Mandalia, S., & Imami, N. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00206 · Cited by 21
“Increased proportions of highly differentiated CD8 T-cells also have been shown to correlate with disease progression (29), and so the reversal of this skewing toward normalization in the CD8 T-cell compartment after 24 wks of MVC, suggests favorable impact on clinical outcome.”
BackgroundPrinciples of Memory CD8 T-Cells Generation in Relation to Protective Immunity
Zanetti, M., Castiglioni, P., & Ingulli, E. G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_9 · Cited by 24
Torrentes‐Carvalho, A., Hottz, E. D., Marinho, C. F., da Silva, J. B. C., Pinto, L. M. D. O., Fialho, L. G., Bozza, F. A., da Cunha, R. V., Damasco, P. V., Kubelka, C. F., et al. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.01.005 · Cited by 20
Gumbi, P. P., Jaumdally, S. Z., Salkinder, A. L., Burgers, W. A., Mkhize, N. N., Hanekom, W. A., Coetzee, D. J., Williamson, A., & Passmore, J.-A. S. (2011) · Journal of Virology · doi:10.1128/jvi.05671-11 · Cited by 21
“tral memory (CM; CD45RA CCR7 ) 3 “intermediate effector memory” (EM; CD45RA CCR7 )3 “late” terminally differentiated cells (TD; CD45RA CCR7 ) (18, 31, 34).”
BackgroundResultCytomegalovirus and Immunological Aging: The Real Driver of HIV and Heart Disease?
Aiello, A. E., & Simanek, A. M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis288 · Cited by 20
“and/or heightened response to normal levels of subclinical CMV replication [10, 11].”
BackgroundNicoli, F., Gallerani, E., Sforza, F., Finessi, V., Chachage, M., Geldmacher, C., Cafaro, A., Ensoli, B., Caputo, A., & Gavioli, R. (2017) · AIDS · doi:10.1097/qad.0000000000001734 · Cited by 24
Memory CD8+ T cell differentiation in viral infection: A cell for all seasons
Radziewicz, H., Uebelhoer, L., Bengsch, B., & Grakoui, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i36.4848 · Cited by 21
Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review
Mishra, K. P., Singh, M., Saraswat, D., Ganju, L., & Varshney, R. K. (2022) · Viral Immunology · doi:10.1089/vim.2022.0002 · Cited by 19
“…exhausted T cells also express a high level of other IRs such as lymphocyte-activation protein 3 (LAG-3), T cell immunoglobulin and mucin-domain containing-3 (TIM-3), T cell immune receptor with Ig and ITIM domains (TIGIT), and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) (4,34,48,64).”
Poudel, K. C., Bertone‐Johnson, E. R., & Poudel‐Tandukar, K. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0520-3 · Cited by 23
Impact of antigen specificity on CD4+T cell activation in chronic HIV-1 infection
Smith, M. Z., Bastidas, S., Karrer, U., & Oxenius, A. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-100 · Cited by 19
“Moreover, primary HIV infection has been shown to cause low-level activation of CD8 T cells specific for CMV and EBV (and influenza, although this is not a persistent antigen) [40,41] and treating HIV-infected patients with an anti-herpesvirus drug reduced CD8 T cell activation [42].”
BackgroundLichtenstein, K. A., Armon, C., Nagabhushanam, V., Efaw, B. J., Frazer‐Abel, A. A., Hiserote, M., & Alam, R. (2012) · Antiviral Therapy · doi:10.3851/imp2350 · Cited by 19
Interactive association of proviral load and IFN-γ-secreting T cell responses in HIV-1C infection
Novitsky, V., Gilbert, P. B., Shea, K. M., McLane, M. F., Rybak, N., Klein, I., Thior, I., Ndung’u, T., Lee, T.-H., & Essex, M. (2006) · Virology · doi:10.1016/j.virol.2006.02.006 · Cited by 20
“This inadequate immune control of virus replication by virus-specific T cell responses can be at least partially explained by the compromised function of T cell responses (Appay et al., 2002; Champagne et al., 2001; Harari et al., 2004; Lichterfeld et al., 2004a; Migueles et al., 2002; Onlamoon et al., 2004; Papagno e…”
BackgroundFardoos, R., Nyquist, S. K., Asowata, O. E., Kazer, S. W., Singh, A., Ngoepe, A., Giandhari, J., Mthabela, N., Ramjit, D., Singh, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912038 · Cited by 19
Puan, K. J., Low, J. S. H., Tan, T. W. K., Wee, J. T. S., Tan, E. H., Fong, K. W., Chua, E. T., Jin, C., Giner, J., Morita, C. T., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0629-8 · Cited by 18
“In contrast, other persistent viral infections deplete CD8 TCM cells by driving their diVerentiation to the CD27¡ CD28¡ terminally diVerentiated phenotype [35].”
BackgroundPhenotypic Characterization of Lymphocytes in HCV/HIV Co-infected Patients
Roe, B., Coughlan, S., Dean, J., Lambert, J. S., Keating, S., Norris, S., Bergin, C. J., & Hall, W. W. (2009) · Viral Immunology · doi:10.1089/vim.2008.0074 · Cited by 19
“Since CD4 T cells play an important role in the activation of cytotoxic CD8 T cells, this lack of CD4 effector cells in HCV/HIV co-infected patients could contribute to the dysfunctional effector CD8 T-cell responses observed in the progression of HIV infection (26,31), and could also contribute to the reduced efficac…”
InfluentialSubset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection
Nikolova, M. H., Wiedemann, A., Muhtarova, M., Achkova, D., Lacabaratz, C., & Lévy, Y. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005995 · Cited by 19
Appay, V., Speiser, D. E., Rufer, N., Reynard, S., Barbey, C., Cerottini, J., Leyvraz, S., Pinilla, C., & Romero, P. J. (2006) · European Journal of Immunology · doi:10.1002/eji.200535805 · Cited by 18
Self-citationRegulatory T Cells and HIV-1 Infection
Terzieva, V. I. (2008) · Viral Immunology · doi:10.1089/vim.2008.0006 · Cited by 18
Rufer, N., Reichenbach, P., & Romero, P. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-862-5:265 · Cited by 20
Self-citationLara‐Aguilar, V., Llamas-Adán, M., Brochado‐Kith, O., Crespo‐Bermejo, C., Grande‐García, S., Arca-Lafuente, S., Santos, I. D. L., PRADO, C. M. C. O., Alía, M., Sainz-Pinós, C., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01064-z · Cited by 22
White, E., Papagno, L., Samri, A., Sugata, K., Hejblum, B. P., Henry, A. R., Rogan, D. C., Darko, S. W., Recordon-Pinson, P., Dudoit, Y., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01931-9 · Cited by 21
“In these individuals (progressors), ongo - ing antigen stimulation continually activates and eventually exhausts length erosion and reduced telomerase activity 18 , which are characteristics of immune senescence 19 .”
Self-citationImmune‐Based Therapy for HIV Infection: Are Acute and Chronic HIV Infection Different Diseases?
Hunt, P. W., & Deeks, S. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/509627 · Cited by 20
“Could cyclosporin A (and/or other immunebased therapeutics) alter the initial hostvirus interactions early and therefore provide sustained clinical benefits? This raises yet another critical question that remains unanswered: how does HIV cause sustained increases in T cell activation? Direct antigen stimulation cannot…”
BackgroundPoudel‐Tandukar, K., & Chandyo, R. K. (2016) · Food and Nutrition Bulletin · doi:10.1177/0379572116657268 · Cited by 18
“The median (range) CD4þ Tcell count in women (360 [15-1551] cells/mL) was significantly greater than that in men (333 [41-962] cells/mL; P 1⁄4 .”
BackgroundСайдакова, Е. В., Владимирович, Ш. К., Korolevskaya, L. B., Геннадьевна, Ш. Н., & Черешнев, В. А. (2018) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1801_15 · Cited by 20
HIV increases sleep-based brain age despite antiretroviral therapy
Leone, M. J., Sun, H., Boutros, C. L., Liu, L., Ye, E. M., Sullivan, L., THOMAS, R. J., Robbins, G. K., Mukerji, S. S., & Westover, M. B. (2021) · SLEEP · doi:10.1093/sleep/zsab058 · Cited by 19
“Prior work has established that PLWH are at increased risk of advanced aging, [33] with previously discovered biomarkers such as somatic mitochondrial DNA mutations [34, 35] and markers of T-cell senescence [36], and decreased HLA methylation levels [37], telomere length [38, 39], and MRI.”
BackgroundEriksson, E. M., Keh, C. E., Deeks, S. G., Martin, J. N., Hecht, F. M., & Nixon, D. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051696 · Cited by 17
“CD96 is Down-regulated Following Stimulation with LPS Chronic immune activation is a well-established characteristic of HIV-1 infection and has been associated with factors such as inflammatory responses, the presence of LPS in plasma as a consequence of microbial translocation [20] and low levels of virus replication…”
BackgroundPinto, K. G., Nascimento, D. O., Corrêa-Ferreira, A., Morrot, A., Freire-de-Lima, C. G., Lopes, M. F., DosReis, G. A., & Filardy, A. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01569 · Cited by 22
Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence
Franzese, O., Barbaccia, M. L., Bonmassar, E., & Graziani, G. (2018) · Chemotherapy · doi:10.1159/000487534 · Cited by 18
Behrens, N. E., Wertheimer, A. M., Klotz, S. A., & Ahmad, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199101 · Cited by 20
Chronic Lung Disease in HIV Patients
Santoro, A., Guaraldi, G., Besutti, G., Leung, J. M., Fabbri, L. M., & Neri, S. (2018) · Aids Reviews · doi:10.24875/aidsrev.18000002 · Cited by 16
Adipose Tissue T Cells in HIV/SIV Infection
Wanjalla, C. N., McDonnell, W. J., & Koethe, J. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02730 · Cited by 16
Echeverría, A., Moro‐García, M. A., Asensi, V., Carton, J. A., López‐Larrea, C., & Alonso‐Arias, R. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0514-276rr · Cited by 17
“Loss of CD28 expression in highly differentiated T lymphocytes is a key predictor of immune incompetence in the elderly and HIV-infected individuals [9].”
BackgroundJin, C., Cheng, L., Lu, X., Xie, T., Wu, H., & Wu, N. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6755 · Cited by 16
“These results are consistent with previous studies, which reported that the majority of circulating CD8 + T cells in individuals with chronic HIV-1 infection were mature effector and effector memory CD8 + T cells (23,24).”
Profile of Immunologic Recovery in HIV-Infected Ugandan Adults after Antiretroviral Therapy
Baker, C. A. R., Emenyonu, N. I., Ssewanyana, I., Jones, N. G., Elrefaei, M., Nghania, F., Nakiwala, J. K., Andia, I., Clark, R. A. F., Martin, J. N., et al. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0309 · Cited by 16
CD57 T cells associated with immunosenescence in adults living with HIV or AIDS
Júnior, E. E., Gubert, V. T., Jacob, C. M. B., Puga, M. A. M., Gouveia, C. G., Sichinel, Â. H., & Tozetti, I. A. (2023) · Immunology · doi:10.1111/imm.13707 · Cited by 16
“The natural effects of aging are expected in the elderly; however, people diagnosed with chronic infections such as HIV may be subject to an early and accelerated immune aging process that predispose them to other chronic diseases, which is typical in older adults [12, 13].”
BackgroundResultInfluentialRamana, K. V. (2014) · American journal of public health research · doi:10.12691/ajphr-2-3-1 · Cited by 20
“After the initiation of antiretroviral therapy, the activity of various cytokines and chemokines were elaborated by various working groups and found contrasting results [35,36,37].”
ResultFalcinelli, S. D., Volkheimer, A. D., Semenova, L., Wu, E., Richardson, A., Ashokkumar, M., Margolis, D. M., Archin, N. M., Rudin, C. D., Murdoch, D. M., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad364 · Cited by 19
Saeidi, A., Chong, Y. K., Yong, Y. K., Tan, H. Y., Barathan, M., Rajarajeswaran, J., Sabet, N. S., Sekaran, S. D., Ponnampalavanar, S. S. L., Che, K. F., et al. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.05.005 · Cited by 15
“Loss of CD27 and CD28 with concurrent up-regulation of CD57 reportedly reflects replicative inability [42].”
BackgroundMaffei, V. J., Siggins, R. W., Luo, M., Brashear, M. M., Mercante, D. E., Taylor, C. M., Molina, P. E., & Welsh, D. A. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa461 · Cited by 19
Shankar, E. M., Velu, V., Kamarulzaman, A., & Larsson, M. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i1.17 · Cited by 15
CD8 T cell effector maturation in HIV-1-infected children
Jordan, K. A., Furlan, S. N., Gonzalez, V. D., Karlsson, A. C., Quigley, M. F., Deeks, S. G., Rosenberg, M. G., Nixon, D. F., & Sandberg, J. K. (2006) · Virology · doi:10.1016/j.virol.2005.12.002 · Cited by 16
Weekes, M. P., Wills, M. R., Sissons, J. G. P., & Carmichael, A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02334.x · Cited by 14
Harcourt, G., Donfield, S. M., Gomperts, E. D., Daar, E. S., Goulder, P., Phillips, R. E., & Klenerman, P. (2005) · AIDS · doi:10.1097/01.aids.0000176213.10367.05 · Cited by 14
“The question of the functionality of HIV-specific CD8 T cells has been addressed before in various studies [34,38], although with discrepant results.”
ResultRéthi, B., Vivar, N., Sammicheli, S., & Chiodi, F. (2009) · AIDS · doi:10.1097/qad.0b013e3283298572 · Cited by 13
Nechvátalová, J., Pavlík, T., Litzman, J., & Vlková, M. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2017.70966 · Cited by 13
“The link between CD8 memory differentiation and immune activation was previously described [34].”
BackgroundMitochondrial DNA Decline in T Cells of HIV‐1 Seroconverters May Be Dependent on Immune Activation
Casula, M., Vrisekoop, N., Wit, F. W. N. M., de Baar, M. P., de Ronde, A., Miedema, F. F., & Reiss, P. (2007) · The Journal of Infectious Diseases · doi:10.1086/519284 · Cited by 13
“As already mentioned, the CD4 and CD8 T cell pool has been reported to undergo considerable expansion and differentiation during chronic immune activation, and the T cell dynamics differ according to the activation state within these cell subsets [15, 22], leading to a changed metabolism [23].”
BackgroundSilva-Freitas, M. L., Corrêa-Castro, G., Da‐Cruz, A. M., & Santos-Oliveira, J. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1516176 · Cited by 13
Assessment of CD8+ T Cell Differentiation in Trypanosoma cruzi-Infected Children
Albareda, M. C., Olivera, G. C., Rissio, A. M. D., & Postan, M. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0604 · Cited by 12
Ghosh, S., Sarkar, M., Ghosh, T., Guha, I., Bhuniya, A., Saha, A., Dasgupta, S., Barik, S., Bose, A., & Baral, R. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.056 · Cited by 12
Utilizing alternate target cells in treating HIV infection through scheduled treatment
Zurakowski, R., Teel, A. R., & Wodarz, D. (2004) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc.2004.1383729 · Cited by 12
“However, throughout all stages of infection, HIV-infected patients have abnormally high levels of helper-T activation in the non HIV-specific compartment as well [8], [4].”
BackgroundUtilizing alternate target cells in treating HIV infection through scheduled treatment interruptions
Zurakowski, R., Teel, A. R., & Wodarz, D. (2004) · Cited by 12
Mbow, M., Santos, N. S. S., Camara, M., Ba, A., Niang, A., Daneau, G., Wade, D., Diallo, A. A., Toupane, M., Diakhaté, M., et al. (2013) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v2i1.76 · Cited by 11
Newman, M. J., Kraus, P. S., Shermock, K. M., Lau, B. D., Haut, E. R., Hobson, D. B., & Streiff, M. B. (2014) · Journal of Hospital Medicine · doi:10.1002/jhm.2156 · Cited by 11
Dock, J., Hultin, L. E., Hultin, P. M., Elliot, J. E., Yang, O. O., Anton, P. A., Jamieson, B. D., & Effros, R. B. (2017) · Journal of Immunological Methods · doi:10.1016/j.jim.2017.03.014 · Cited by 14
Eberhard, J. M., Ahmad, F., Hong, H. S., Bhatnagar, N., Keudel, P., Wiesch, J. S. Z., Schmidt, R. E., & Meyer‐Olson, D. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12837 · Cited by 15
Clutton, G., Weideman, A. M., Goonetilleke, N. P., & Maurer, T. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.961021 · Cited by 14
“Since highly differentiated T cells accumulate during chronic untreated infections (Papagno et al., 2004; Unemori et al., 2013), we next compared the differentiation state of CD8bright and CD8dim cells within participants.”
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis
Negash, M., Chanyalew, M., Girma, T., Alemu, F., Alcantara, D., Towler, B. P., Davey, G., Boyton, R. J., Altmann, D. M., Howe, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46347-z · Cited by 12
“In fact, in studies of HIV in particular it would appear that the vast majority of activated T cells are not HIV-speci fi c 33 , raising the question as to whether expression of activation markers in chronic diseases necessarily re fl ects a presumed antigen induction.”
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.